AmerisourceBergen aims to connect trial sponsors with cancer practices
FierceCRO
Independent specialty practices are an untapped recruitment opportunity for clinical trials, says AmerisourceBergen, which has launched a tool that connects drug developers with oncology practices. The technology–called Clinical Trial Navigator–is a software platform that supports recruitment for biopharmaceutical companies’ clinical trials, according to AmerisourceBergen spokeswoman Francesca LaMonaca. The platform will help connect biopharma companies with independent oncology practice groups across the country, LaMonaca told Fierce Biotech. She added that AmerisourceBergen already works with thousands of independent specialty physician practices nationwide.
For the full article, please visit FierceCRO.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.